A BEAUTY and cosmetics company said it is willing to pull out some of its products from the market but clarified that it had nothing to do with their quality, rather with their registration that has been pending before the Food and Drug Administration (FDA).

In a statement, John Eric Ho, the corporate communications head of the Belo Medical Group (BMG), said that the firm shared the FDA objective to protect public health by making certain all drugs sold to them are safe and appropriately registered.